Skip to content

Clinical trials

Phase 2 Thyroid Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Phase: Phase 2 Country / region: France Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20051
20073
20081
20091
20111
20132
20142
20152
20161
20173

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Inc.3
Assistance Publique - Hôpitaux de Paris2
Genzyme, a Sanofi Company2
Amgen1
Apollomics Inc.1
Bayer1
Centre Henri Becquerel1
Centre Leon Berard1
European Organisation for Research and Treatment of Cancer - EORTC1
Gustave Roussy, Cancer Campus, Grand Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms20
Neoplasms3
Breast Neoplasms2
Carcinoma, Medullary2
Carcinoma, Non-Small-Cell Lung2
Colonic Neoplasms2
Head and Neck Neoplasms2
Kidney Neoplasms2
Lung Neoplasms2
Sarcoma2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.